Converge Biotech Announces Collaboration With OncoDNA to Personalize Cancer Care in India
Tuesday, February 9, 2021 11:40AM IST (6:10AM GMT)
Hyderabad, Telangana, India: Converge Biotech, a leading healthcare organization based in Hyderabad, has announced today that it has entered into a long-term strategic alliance with OncoDNA, a Belgium-based theranostic and genomic company specializing in precision oncology, to personalize care for late stage cancer patients across India. OncoDNA’s solutions are designed to guide oncologists in the selection of the most appropriate treatments based on the specific tumor profile of a patient.
With the aim of improving the clinical outcomes of patients living with advanced solid tumors such as breast or lung cancers, Converge Biotech will provide physicians and healthcare providers across India with OncoDNA’s portfolio of comprehensive diagnostic solutions that include:
Converge Biotech, OncoDNA offer personalised cancer care
Converge Biotech, OncoDNA offer personalised cancer care
09 February 2021 | News OncoDNA’s solutions are designed to guide oncologists in the selection of the most appropriate treatments based on the specific tumour profile of a patient
Source credit: Shutterstock
Converge Biotech, a leading healthcare organisation based in Hyderabad has announced that it has entered into a long-term strategic alliance with OncoDNA, a Belgium-based theranostic and genomic company specialising in precision oncology, to personalise care for late-stage cancer patients across India. OncoDNA’s solutions are designed to guide oncologists in the selection of the most appropriate treatments based on the specific tumour profile of a patient.